Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q4 2017 · 10-K
Revenue$662.00K$662.00K−54.8% vs Q4 2016 Net Income-$4.29M-$4.29MN/M vs Q4 2016 EPS Diluted-$0.20-$0.20N/M vs Q4 2016 Gross Profit$29,000−94.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$4,224,000N/M Free Cash Flowderived-$4,248,000N/M Margins · derivedGross margin4.4%−31.2 pt vs Q4 2016
Operating margin-548.3%−303.6 pt vs Q4 2016
Net margin-647.4%−312.0 pt vs Q4 2016
ended Dec 31, 2017 · filed Mar 9, 2018 · 68 d after period end